Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Novel prognostic index for pediatric ALL

Anthony Moorman • 22 Jun 2020
EHA 2020
Acute Lymphoblastic Leukemia Leukemia
UKALL2003

Anthony Moorman, PhD, Newcastle University, Newcastle, UK describes a novel continuous prognostic index and its use for delivering stratified medicine in pediatric acute lymphoblastic leukemia (ALL). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Anthony Moorman

5:23
Redefining low risk high hyperdiploidy in pediatric ALL
Anthony Moorman • 8 Jun 2021
4:31
T-ALL diagnosis: cytogenetics, genomics and risk assessment
Anthony Moorman • 8 Jun 2021
2:44
Impact of genomics in the future of ALL treatment
Anthony Moorman • 8 Jun 2021
3:02
Enhanced risk stratification in pediatric ALL
Anthony Moorman • 10 Nov 2020

Related Videos

1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals